• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Restoring placental growth factor-soluble fms-like tyrosine kinase-1 balance reverses vascular hyper-reactivity and hypertension in pregnancy.恢复胎盘生长因子与可溶性fms样酪氨酸激酶-1的平衡可逆转妊娠期血管高反应性和高血压。
Am J Physiol Regul Integr Comp Physiol. 2016 Sep 1;311(3):R505-21. doi: 10.1152/ajpregu.00137.2016. Epub 2016 Jun 8.
2
Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.胎盘生长因子可逆转高血压妊娠中血管和胎盘基质金属蛋白酶-2 和基质金属蛋白酶-9 的减少,以及基质金属蛋白酶-1 和基质金属蛋白酶-7 和 I 型和 IV 型胶原的增加。
Am J Physiol Heart Circ Physiol. 2018 Jul 1;315(1):H33-H47. doi: 10.1152/ajpheart.00045.2018. Epub 2018 Mar 23.
3
Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.血管生成失衡以及基质金属蛋白酶-2和-9减少是妊娠期高血压疾病患者子宫胎盘血管化及胎儿-胎盘生长局部减少的潜在原因。
Biochem Pharmacol. 2017 Dec 15;146:101-116. doi: 10.1016/j.bcp.2017.09.005. Epub 2017 Sep 11.
4
Altered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy.基质金属蛋白酶-2和-9表达/活性的改变将胎盘缺血和抗血管生成的可溶性fms样酪氨酸激酶-1与高血压妊娠时子宫胎盘及血管重塑和胶原沉积联系起来。
Biochem Pharmacol. 2014 Jun 1;89(3):370-85. doi: 10.1016/j.bcp.2014.03.017. Epub 2014 Apr 3.
5
Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat.妊娠大鼠子宫灌注压降低期间内皮依赖性血管舒张功能减退。
Hypertension. 2000 Jan;35(1 Pt 2):367-72. doi: 10.1161/01.hyp.35.1.367.
6
Downregulation of microvascular endothelial type B endothelin receptor is a central vascular mechanism in hypertensive pregnancy.微脉管内皮 B 型内皮素受体下调是高血压妊娠中血管的核心机制。
Hypertension. 2014 Sep;64(3):632-43. doi: 10.1161/HYPERTENSIONAHA.114.03315. Epub 2014 Jun 9.
7
TNFα blockade reverses vascular and uteroplacental matrix metalloproteinases imbalance and collagen accumulation in hypertensive pregnant rats.TNFα 阻断可逆转高血压孕妇血管和胎盘基质金属蛋白酶失衡及胶原积累。
Biochem Pharmacol. 2021 Nov;193:114790. doi: 10.1016/j.bcp.2021.114790. Epub 2021 Oct 1.
8
High-salt diet enhances vascular reactivity in pregnant rats with normal and reduced uterine perfusion pressure.高盐饮食增强子宫灌注压正常和降低的妊娠大鼠的血管反应性。
Hypertension. 2001 Sep;38(3 Pt 2):730-5. doi: 10.1161/01.hyp.38.3.730.
9
Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension.给予胎盘生长因子可消除胎盘缺血诱导的高血压。
Hypertension. 2016 Apr;67(4):740-7. doi: 10.1161/HYPERTENSIONAHA.115.06783. Epub 2016 Feb 1.
10
Vitamin D Supplementation Prevents Placental Ischemia Induced Endothelial Dysfunction by Downregulating Placental Soluble FMS-Like Tyrosine Kinase-1.补充维生素D通过下调胎盘可溶性FMS样酪氨酸激酶-1预防胎盘缺血诱导的内皮功能障碍。
DNA Cell Biol. 2017 Dec;36(12):1134-1141. doi: 10.1089/dna.2017.3817. Epub 2017 Oct 5.

引用本文的文献

1
Pharmacologic and endotoxic reprogramming of renal vasodilatory, inflammatory, and apoptotic blemishes in weaning preeclamptic rats.断奶期先兆子痫大鼠肾血管舒张、炎症及凋亡缺陷的药理学和内毒素重编程
Sci Rep. 2025 Mar 8;15(1):8137. doi: 10.1038/s41598-025-87586-4.
2
Impaired Endothelium-Dependent Vasodilation and Increased Levels of Soluble Fms-like Tyrosine Kinase-1 Induced by Reduced Uterine Perfusion Pressure in Pregnant Rats: Evidence of Protective Effects with Sodium Nitrite Treatment in Preeclampsia.在患有先兆子痫的怀孕大鼠中,降低子宫灌注压可导致内皮依赖性血管舒张功能受损和可溶性 Fms 样酪氨酸激酶-1 水平升高:亚硝酸钠治疗的保护作用证据。
Int J Mol Sci. 2024 Oct 15;25(20):11051. doi: 10.3390/ijms252011051.
3
Both endothelial mineralocorticoid receptor expression and hyperleptinemia are required for clinical characteristics of placental ischemia in mice.内皮细胞盐皮质激素受体表达和高瘦素血症是导致小鼠胎盘缺血临床特征所必需的。
Am J Physiol Heart Circ Physiol. 2024 Jul 1;327(1):H118-H130. doi: 10.1152/ajpheart.00188.2024. Epub 2024 May 17.
4
Isoflurane increases the activity of the vascular matrix metalloproteinase-2 in non-pregnant rats and increases the nitric oxide metabolites in pregnancy.异氟烷会增加非妊娠大鼠血管基质金属蛋白酶-2 的活性,并增加妊娠期间的一氧化氮代谢物。
Biosci Rep. 2024 Jun 26;44(6). doi: 10.1042/BSR20240192.
5
Increased uterine arterial tone, stiffness and remodeling with augmented matrix metalloproteinase-1 and -7 in uteroplacental ischemia-induced hypertensive pregnancy.子宫胎盘缺血诱导的高血压妊娠中子宫动脉张力增加、僵硬及重塑,同时基质金属蛋白酶-1和-7增多。
Biochem Pharmacol. 2024 Oct;228:116227. doi: 10.1016/j.bcp.2024.116227. Epub 2024 Apr 19.
6
Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach.采用实验设计方法对用于胎盘mRNA递送的可电离脂质纳米颗粒进行系统开发。
Bioact Mater. 2023 Dec 22;34:125-137. doi: 10.1016/j.bioactmat.2023.11.014. eCollection 2024 Apr.
7
Regulation of vascular angiotensin II type 1 and type 2 receptor and angiotensin-(1-7)/MasR signaling in normal and hypertensive pregnancy.正常妊娠和高血压妊娠中血管紧张素 II 型 1 和 2 型受体及血管紧张素-(1-7)/MasR 信号的调节。
Biochem Pharmacol. 2024 Feb;220:115963. doi: 10.1016/j.bcp.2023.115963. Epub 2023 Dec 5.
8
Sodium Nitrite Attenuates Reduced Activity of Vascular Matrix Metalloproteinase-2 and Vascular Hyper-Reactivity and Increased Systolic Blood Pressure Induced by the Placental Ischemia Model of Preeclampsia in Anesthetized Rats.亚硝酸盐钠可减轻血管基质金属蛋白酶-2活性降低、血管高反应性和先兆子痫胎盘缺血模型引起的麻醉大鼠收缩压升高。
Int J Mol Sci. 2023 Aug 15;24(16):12818. doi: 10.3390/ijms241612818.
9
Increased Ca-dependent intrinsic tone and arterial stiffness in mesenteric microvessels of hypertensive pregnant rats.高血压孕妇大鼠肠系膜微血管中钙依赖性内在张力和动脉僵硬增加。
Biochem Pharmacol. 2023 Feb;208:115353. doi: 10.1016/j.bcp.2022.115353. Epub 2022 Nov 24.
10
Reliability of Rodent and Rabbit Models in Preeclampsia Research.啮齿动物和兔模型在子痫前期研究中的可靠性。
Int J Mol Sci. 2022 Nov 18;23(22):14344. doi: 10.3390/ijms232214344.

本文引用的文献

1
Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension.给予胎盘生长因子可消除胎盘缺血诱导的高血压。
Hypertension. 2016 Apr;67(4):740-7. doi: 10.1161/HYPERTENSIONAHA.115.06783. Epub 2016 Feb 1.
2
Sildenafil Treatment Ameliorates the Maternal Syndrome of Preeclampsia and Rescues Fetal Growth in the Dahl Salt-Sensitive Rat.西地那非治疗可改善子痫前期的母体综合征并挽救 Dahl 盐敏感大鼠的胎儿生长。
Hypertension. 2016 Mar;67(3):647-53. doi: 10.1161/HYPERTENSIONAHA.115.06071. Epub 2016 Jan 4.
3
Adaptive increases in expression and vasodilator activity of estrogen receptor subtypes in a blood vessel-specific pattern during pregnancy.孕期雌激素受体亚型以血管特异性模式适应性增加表达及血管舒张活性。
Am J Physiol Heart Circ Physiol. 2015 Nov 15;309(10):H1679-96. doi: 10.1152/ajpheart.00532.2015. Epub 2015 Sep 25.
4
Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia.硫酸葡聚糖单采术清除子痫前期患者可溶性Fms样酪氨酸激酶-1的研究
J Am Soc Nephrol. 2016 Mar;27(3):903-13. doi: 10.1681/ASN.2015020157. Epub 2015 Sep 24.
5
Increased circulating interleukin-17 levels in preeclampsia.子痫前期患者循环中白细胞介素-17水平升高。
J Reprod Immunol. 2015 Nov;112:53-7. doi: 10.1016/j.jri.2015.05.007. Epub 2015 Jun 23.
6
Circulating endothelial cell number and markers of endothelial dysfunction in previously preeclamptic women.既往患先兆子痫女性的循环内皮细胞数量及内皮功能障碍标志物
Am J Obstet Gynecol. 2015 Oct;213(4):533.e1-7. doi: 10.1016/j.ajog.2015.06.043. Epub 2015 Jun 25.
7
Is the imbalance between pro-angiogenic and anti-angiogenic factors associated with preeclampsia?促血管生成和抗血管生成因子失衡与子痫前期有关吗?
Clin Chim Acta. 2015 Jul 20;447:34-8. doi: 10.1016/j.cca.2015.05.004. Epub 2015 May 13.
8
Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia.循环血管生成因子与海地先兆子痫妇女不良结局风险
PLoS One. 2015 May 12;10(5):e0126815. doi: 10.1371/journal.pone.0126815. eCollection 2015.
9
Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.子宫胎盘循环和全身循环中的生物活性因子将胎盘缺血与妊娠期高血压疾病和子痫前期的全身性血管功能障碍联系起来。
Biochem Pharmacol. 2015 Jun 15;95(4):211-26. doi: 10.1016/j.bcp.2015.04.012. Epub 2015 Apr 24.
10
First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia.孕早期母体血清中可溶性血管内皮生长因子受体1、前列腺素F和不对称二甲基精氨酸水平可预测子痫前期。
PLoS One. 2015 Apr 23;10(4):e0124684. doi: 10.1371/journal.pone.0124684. eCollection 2015.

恢复胎盘生长因子与可溶性fms样酪氨酸激酶-1的平衡可逆转妊娠期血管高反应性和高血压。

Restoring placental growth factor-soluble fms-like tyrosine kinase-1 balance reverses vascular hyper-reactivity and hypertension in pregnancy.

作者信息

Zhu Minglin, Ren Zongli, Possomato-Vieira José S, Khalil Raouf A

机构信息

Vascular Surgery Research Laboratories, Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.

Vascular Surgery Research Laboratories, Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts

出版信息

Am J Physiol Regul Integr Comp Physiol. 2016 Sep 1;311(3):R505-21. doi: 10.1152/ajpregu.00137.2016. Epub 2016 Jun 8.

DOI:10.1152/ajpregu.00137.2016
PMID:27280428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5142222/
Abstract

Preeclampsia (PE) is a pregnancy-related hypertensive disorder (HTN-Preg) with unclear mechanism. An imbalance between antiangiogenic soluble fms-like tyrosine kinase-1 (sFlt-1) and angiogenic placental growth factor (PlGF) has been observed in PE, but the vascular targets and signaling pathways involved are unclear. We assessed the extent of sFlt-1/PlGF imbalance and vascular dysfunction in a rat model of HTN-Preg produced by reduction of uteroplacental perfusion pressure (RUPP), and tested whether inducing a comparable sFlt-1/PlGF imbalance by infusing sFlt-1 (10 μg·kg(-1)·day(-1)) in day 14 pregnant (Preg) rats cause similar increases in blood pressure (BP) and vascular reactivity. Using these guiding measurements, we then tested whether restoring sFlt-1/PlGF balance by infusing PIGF (20 μg·kg(-1)·day(-1)) in RUPP rats would improve BP and vascular function. On gestational day 19, BP was in Preg+sFlt-1 and RUPP > Preg, and in RUPP+PlGF < RUPP rats. Plasma sFlt-1/PlGF ratio was increased in Preg+sFlt-1, and RUPP and was reduced in RUPP+PlGF rats. In isolated endothelium-intact aorta, carotid, mesenteric, and renal artery, phenylephrine (Phe)- and high KCl-induced contraction was in Preg+sFlt-1 and RUPP > Preg, and in RUPP+PlGF < RUPP. The differences in vascular reactivity to Phe and KCl between groups were less apparent in vessels treated with the nitric oxide synthase (NOS) inhibitor l-NAME or guanylate cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) or endothelium-denuded, suggesting changes in endothelial NO-cGMP pathway. In Phe precontracted vessels, ACh-induced relaxation was in Preg+sFlt-1 and RUPP < Preg, and in RUPP+PlGF > RUPP, and was blocked by N(ω)-nitro-l-arginine methyl ester (l-NAME) or ODQ treatment or endothelium removal. Western blots revealed that aortic total endothelial NOS (eNOS) and activated phosphorylated-eNOS were in Preg+sFlt-1 and RUPP < Preg and in RUPP+PlGF > RUPP. ACh-induced vascular nitrate/nitrite production was in Preg+sFlt-1 and RUPP < Preg, and in RUPP+PlGF > RUPP. Vascular relaxation to the exogenous NO donor sodium nitroprusside was not different among groups. Thus, a tilt in the angiogenic balance toward anti-angiogenic sFlt-1 is associated with decreased vascular relaxation and increased vasoconstriction and BP. Restoring the angiogenic/antiangiogenic balance using PlGF enhances endothelial NO-cGMP vascular relaxation and decreases vasoconstriction and BP in HTN-Preg rats and could offer a new approach in the management of PE.

摘要

子痫前期(PE)是一种机制不明的妊娠相关高血压疾病(HTN-Preg)。在子痫前期患者中观察到抗血管生成的可溶性fms样酪氨酸激酶-1(sFlt-1)与血管生成的胎盘生长因子(PlGF)之间失衡,但所涉及的血管靶点和信号通路尚不清楚。我们评估了子宫胎盘灌注压降低(RUPP)所致的HTN-Preg大鼠模型中sFlt-1/PlGF失衡程度和血管功能障碍,并测试了在妊娠第14天给孕鼠输注sFlt-1(10μg·kg⁻¹·天⁻¹)诱导相似的sFlt-1/PlGF失衡是否会导致血压(BP)和血管反应性类似升高。基于这些指导测量,我们随后测试了在RUPP大鼠中输注PlGF(20μg·kg⁻¹·天⁻¹)恢复sFlt-1/PlGF平衡是否会改善血压和血管功能。在妊娠第19天,Preg+sFlt-1组和RUPP组的血压高于Preg组,而RUPP+PlGF组的血压低于RUPP组。Preg+sFlt-1组和RUPP组的血浆sFlt-1/PlGF比值升高,而RUPP+PlGF组降低。在分离的完整内皮主动脉、颈动脉、肠系膜动脉和肾动脉中,去氧肾上腺素(Phe)和高钾诱导的收缩在Preg+sFlt-1组和RUPP组高于Preg组,而在RUPP+PlGF组低于RUPP组。在用一氧化氮合酶(NOS)抑制剂L-NAME或鸟苷酸环化酶抑制剂1H-[1,2,4]恶二唑并[4,3-a]喹喔啉-1-酮(ODQ)处理的血管或内皮剥脱的血管中,各组之间对Phe和氯化钾的血管反应性差异不太明显,提示内皮一氧化氮-cGMP途径发生改变。在Phe预收缩的血管中,乙酰胆碱(ACh)诱导的舒张在Preg+sFlt-1组和RUPP组低于Preg组,而在RUPP+PlGF组高于RUPP组,并且被N(ω)-硝基-L-精氨酸甲酯(L-NAME)或ODQ处理或去除内皮所阻断。蛋白质免疫印迹显示,主动脉总内皮型一氧化氮合酶(eNOS)和活化的磷酸化-eNOS在Preg+sFlt-1组和RUPP组低于Preg组,而在RUPP+PlGF组高于RUPP组。ACh诱导的血管硝酸盐/亚硝酸盐生成在Preg+sFlt-1组和RUPP组低于Preg组,而在RUPP+PlGF组高于RUPP组。各组对外源性一氧化氮供体硝普钠的血管舒张反应无差异。因此,血管生成平衡向抗血管生成的sFlt-1倾斜与血管舒张降低、血管收缩增加和血压升高有关。使用PlGF恢复血管生成/抗血管生成平衡可增强内皮一氧化氮-cGMP血管舒张,降低HTN-Preg大鼠的血管收缩和血压,并可能为子痫前期的管理提供一种新方法。